Depletion of Peripheral Blood CD21+ and CD21- B-cell subsets.

<p>Short and long-term analysis of PBMC B-cell depletion of (<b>A</b>) CD21+ and (<b>B</b>) CD21- B-cell subsets (as identified in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0080533#pone-0080533-g002" target="_blank">Figure 2C</a>). Individuals animal samples with mean shown for baseline, day 2, day 9 and day 14 post second dose (top) and percent remaining as normalized to PBS vehicle treated group (bottom) (group mean ± SD (n=4 rituximab treated groups, n=3 PBS vehicle treated groups).